-
Zheng shocks Swiatek in another incredible US Open comeback
-
CapTLX Launches Institutional Gateway to U.S. Private Markets, Expanding Access to Structured Investment Opportunities
-
Andreeva survives in three sets against Potapova
-
Africa's richest man eyes continent's largest IPO
-
Alleged killers of Australian, US surfers go on trial in Mexico
-
Macron, SKorea leader warn at film summit of AI risks to creativity
-
King Charles classes Harry and Meghan as 'private citizens'
-
'Impressive' Alcaraz has Shelton in sights in US Open quarter-final
-
Bowling coach Noffke says Pakistan's off-field issues are nothing new
-
Noosha Aubel a krize v Postupimi: Jak dlouho je ještě možné tolerovat toto selhání vedení?
-
Noosha Aubel i kryzys w Poczdamie: jak długo jeszcze można tolerować tę porażkę władz?
-
Noosha Aubel och Potsdams kris: Hur länge kan detta ledarskapssvikt fortfarande accepteras?
-
ヌーシャ・オーベルとポツダムの危機:この指導力の欠如は、いつまで容認され続けるのか?
-
Η Noosha Aubel και η κρίση του Πότσνταμ: Για πόσο ακόμα είναι ανεκτή αυτή η διαχειριστική αποτυχία;
-
नूशा ऑबेल और पॉट्सडैम का संकट: नेतृत्व की इस विफलता को और कितना सहन किया जा सकता है?
-
누샤 아우벨과 포츠담의 위기: 이러한 리더십 부재는 얼마나 더 용인될 수 있는가?
-
努莎·奧貝爾與波茨坦的危機:這種領導失職還能容忍多久?
-
نوشا أوبيل وأزمة بوتسدام: إلى متى سيظل هذا الفشل القيادي مقبولاً؟
-
Нуша Аубель і криза в Потсдамі: як довго ще можна миритися з цією неспроможністю керівництва?
-
Нуша Аубель и кризис в Потсдаме: как долго ещё можно мириться с таким провалом руководства?
-
Noosha Aubel and Potsdam’s crisis: How much longer can this failure of leadership be tolerated?
-
England quick Archer in 'good place' after injuries
-
US envoy sees 'movement' toward three-way talks with Russia, Ukraine
-
Robots protest rampant AI in Poland
-
Thousands bid farewell to Bosnian Serb war criminal in Belgrade
-
Rare woman director in Venice sees industry backsliding on gender
-
EU chief announces 200-mn-euro investment package for Greenland
-
France, SKorea warn at film summit of AI risks to creativity
-
Lebanon says Israel conducts wave of deadly strikes
-
Z Traders Introduces New Funding Model Designed to Expand Opportunities in Trading
-
Cipheras Group - Apex AI Fund Deploys 290-Billion-Parameter Proprietary Large Language Model
-
Lebanon says 12 killed in strikes as Israel vows to 'remove threats'
-
Germany's Merz 'shocked' by far-right state win but vows to stay course
-
Volkswagen plant to be converted for Israeli defence group
-
UK finance minister Healey pledges strict fiscal discipline as budget looms
-
Israeli rubble-clearing in Gaza could erase 'atrocity crimes' evidence: UN expert
-
Mbappe embraces Ballon d'Or talk after historic World Cup exploits
-
Scorching summer pushes French wine harvest to new historic low
-
Tech firms rally, with eyes on US inflation update
-
Pietersen joins England coaching team ahead of World Cup
-
Jaguar Land Rover to cut 4,000 jobs as European car sector hits skids
-
Germany's triumphant far-right AfD aims fire at Merz
-
US average diesel price rises to record $5.90 a gallon: AAA
-
Fury claims Joshua bout is off, calls for Usyk trilogy
-
Dukascopy Bank Unveils AI-Powered Trading, 25,000+ Stock CFDs and a New Flagship E-Banking App
-
British family bids to row back against suicide taboo
-
Tech firms rally but Asian markets mixed, with eyes on US inflation
-
China's teenage 223cm basketball player 'just a little girl'
-
Nepal holds day of mourning as families pray missing still alive
-
Tokyo's Shinjuku to ban more than half of vacation rentals
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use
HAYWARD, CALIFORNIA / ACCESS Newswire / July 29, 2025 / Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use. The media and chambers were part of Biolog's acquisition of Anaerobe Systems earlier this year with the objective of bringing class-leading tools for microbiology to the rapidly growing clinical, microbiome, and agricultural markets.
Today, Biolog's TruPRAS™ media is the only commercial media manufactured under true pre-reduced, anaerobically sterilized conditions, preventing the formation of harmful byproducts that can be toxic to anaerobic organisms. This line of media products, which has been approved for In Vitro Diagnostic (IVD) use by the USA FDA for years, has now also achieved CE marking under the requirements of the EU IVDR regulation 2017/746. With zero recalls or field actions throughout their extensive history, these products enable transport of specimens and growth of fastidious anaerobes that play important roles in disease pathology - supporting clinical diagnostics in medical laboratories.
"The IVDR/CE mark is a major milestone that recognizes the high standard of our anaerobic media and its value in supporting critical diagnostic workflows," said Robert Wicke, CEO at Biolog. "We're proud that clinical labs throughout Europe can now benefit from the same reliable performance that researchers and clinicians in the U.S. have trusted for decades."
Biolog's anaerobic chambers have also received the CE mark, affirming their safety and performance for use in any research settings throughout the world. With unique InstaSleeve™ technology, these ergonomic, gloveless chambers offer superior processing dexterity while working in a fully anaerobic environment and are a preferred tool for microbiologists in both clinical and academic settings. In addition, Biolog is releasing an upgrade to enable hypoxic or microaerophilic conditions in the same chamber, for organisms that require specific, low concentrations of oxygen to thrive.
"This dual achievement reinforces Biolog's commitment to advancing global access to high-quality tools for anaerobic microbiology," said Wicke. "Whether you're working with challenging clinical isolates or conducting fundamental research, Biolog now provides dependable CE-marked solutions that meet your needs."
About Biolog
Biolog offers tools, services, and support for comprehensive cellular characterization and multi-omic identification of bacteria, yeast, and fungi. Our products also enable phenotypic profiling of microbial and mammalian cells for a range of applications, including supporting the culture of fastidious anaerobes with our line of gloveless chambers and pre-reduced media. Learn more at biolog.com
Contact Information
John Proctor, Ph.D.
CCO
[email protected]
(408)306-0414
SOURCE: Biolog, Inc.
View the original press release on ACCESS Newswire
X.Karnes--AMWN